10.91 USD
▼-0.14-0.91%
盘后 11.01 0.00%
2026-08-03
市值
$1.23B
市盈率
—
EPS
-8.47
股息率
—
52 周区间
9.95 – 14.47
成交量
600.02K
Beta
0.35
目标价
—
52W 低 9.9552W 高 14.47
价格走势
公司简介
Freenome, Inc. operates as a biotechnology company focused on developing blood-based tests for early cancer detection using artificial intelligence and multiomics technology. The company develops and provides blood-based tests for early cancer detection, including a test for colorectal cancer screening. It offers a multiomics platform that combines computational biology, machine learning, and multiple data types to identify biomarkers and detect various cancers. The company conducts clinical research programs, such as the PREEMPT CRC, Sanderson...